Literature DB >> 12105169

Involvement of glycoprotein VI in platelet thrombus formation on both collagen and von Willebrand factor surfaces under flow conditions.

Shinya Goto1, Noriko Tamura, Shunnosuke Handa, Morio Arai, Kumi Kodama, Hiroshi Takayama.   

Abstract

BACKGROUND: We studied the role of glycoprotein (GP) VI in platelet adhesion and thrombus formation on the immobilized collagen and von Willebrand factor (vWF) surface under flow conditions. METHODS AND
RESULTS: Whole blood obtained from 2 patients with GP VI-deficient platelets and the effects of the Fab of anti-GP VI antibody (Fab/anti-GP VI) were tested. Blood containing platelets rendered fluorescent by mepacrine was perfused on immobilized type I collagen or vWF under controlled wall shear rate. Platelet adhesion and thrombus formation were detected by epifluorescent videomicroscopy. The percentage of surface coverage by the platelets was calculated. Fc receptor gamma-chain and spleen tyrosine kinase (Syk) were immunoprecipitated from the lysate of platelets stimulated by vWF plus ristocetin and then analyzed by antiphosphotyrosine immunoblotting. No platelet attachment was seen on the surface of collagen even after 9 minutes of perfusion of blood at relatively low (100 s(-1)) or high (1500 s(-1)) wall shear rate, either in the case of blood containing GP VI-deficient platelets or in the presence of Fab/anti-GP VI, whereas significant platelet thrombus formation was noted after control blood perfusion. Such interference with the actions of GP VI also reduced firm platelet adhesion on immobilized vWF. vWF-induced tyrosine phosphorylation of GP VI-associated Fc receptor gamma-chain followed by Syk activation occurred in normal platelets, but little activation of Syk occurred in GP VI-deficient platelets.
CONCLUSIONS: GP VI plays crucial roles in platelet thrombus formation on the surface of collagen under flow conditions in humans and is also involved in the process of firm platelet adhesion on the surface of vWF.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12105169     DOI: 10.1161/01.cir.0000021427.87256.7e

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  19 in total

1.  Platelets from mice lacking the aryl hydrocarbon receptor exhibit defective collagen-dependent signaling.

Authors:  S Lindsey; J Jiang; D Woulfe; E T Papoutsakis
Journal:  J Thromb Haemost       Date:  2014       Impact factor: 5.824

Review 2.  Integrin signaling in atherosclerosis.

Authors:  Alexandra C Finney; Karen Y Stokes; Christopher B Pattillo; A Wayne Orr
Journal:  Cell Mol Life Sci       Date:  2017-02-28       Impact factor: 9.261

3.  GPVI and alpha2beta1 play independent critical roles during platelet adhesion and aggregate formation to collagen under flow.

Authors:  Kendra L Sarratt; Hong Chen; Mary M Zutter; Samuel A Santoro; Daniel A Hammer; Mark L Kahn
Journal:  Blood       Date:  2005-05-10       Impact factor: 22.113

4.  A novel antiplatelet antibody therapy that induces cAMP-dependent endocytosis of the GPVI/Fc receptor gamma-chain complex.

Authors:  Hiroshi Takayama; Yoshitaka Hosaka; Kazuyuki Nakayama; Kamon Shirakawa; Katsuki Naitoh; Tomokazu Matsusue; Mikihiko Shinozaki; Motoyasu Honda; Yukiko Yatagai; Tetsushi Kawahara; Jiro Hirose; Tooru Yokoyama; Michiru Kurihara; Shoji Furusako
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

Review 5.  Role of cellular elements in thrombus formation and dissolution.

Authors:  N Wohner
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2008-07

6.  Facilitating roles of murine platelet glycoprotein Ib and alphaIIbbeta3 in phosphatidylserine exposure during vWF-collagen-induced thrombus formation.

Authors:  Marijke J E Kuijpers; Valerie Schulte; Cécile Oury; Theo Lindhout; Jos Broers; Marc F Hoylaerts; Bernhard Nieswandt; Johan W M Heemskerk
Journal:  J Physiol       Date:  2004-05-21       Impact factor: 5.182

7.  Characteristics of endogenous γ-aminobutyric acid (GABA) in human platelets: functional studies of a novel collagen glycoprotein VI inhibitor.

Authors:  Kuan-Hung Lin; Wan-Jung Lu; Shwu-Huey Wang; Tsorng-Harn Fong; Duen-Suey Chou; Chao-Chien Chang; Nen-Chung Chang; Yung-Chen Chiang; Shih-Yi Huang; Joen-Rong Sheu
Journal:  J Mol Med (Berl)       Date:  2014-03-14       Impact factor: 4.599

8.  Flow studies on human GPVI-deficient blood under coagulating and noncoagulating conditions.

Authors:  Magdolna Nagy; Gina Perrella; Amanda Dalby; M Francisca Becerra; Lourdes Garcia Quintanilla; Jeremy A Pike; Neil V Morgan; Elizabeth E Gardiner; Johan W M Heemskerk; Lorena Azócar; Juan Francisco Miquel; Diego Mezzano; Steve P Watson
Journal:  Blood Adv       Date:  2020-07-14

9.  Development of a perfusion chamber assay to study in real time the kinetics of thrombosis and the antithrombotic characteristics of antiplatelet drugs.

Authors:  Gillian Stephens; Ming He; Connie Wong; Marzena Jurek; Hans-Christian Luedemann; Golnaz Shapurian; Kevin Munnelly; Craig Muir; Pamela B Conley; David R Phillips; Patrick Andre
Journal:  Thromb J       Date:  2012-08-01

10.  Bleeding diathesis in mice lacking JAK2 in platelets.

Authors:  Nathan Eaton; Saravanan Subramaniam; Marie L Schulte; Caleb Drew; David Jakab; Sandra L Haberichter; Hartmut Weiler; Hervé Falet
Journal:  Blood Adv       Date:  2021-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.